Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02089334
Title Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell Cancer
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Rexahn Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Rexahn Site Tucson Arizona 85719 United States Details
Rexahn Site Duarte California 91010 United States Details
Rexahn Site Albuquerque New Mexico 87106 United States Details
Rexahn Site Bronx New York 10467 United States Details
Rexahn Site New York New York 10065 United States Details
Rexahn Site Salt Lake City Utah 84112 United States Details
Rexahn Site Seattle Washington 98101 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field